Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |